STOCK TITAN

CompoSecure, Inc. 10-Q Filings

CMPO NYSE

Every 10-Q that CompoSecure, Inc. (CMPO) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow CMPO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CMPO filings page.

Rhea-AI Summary

GPGI, Inc. reported a sharp shift to a net loss of $235.0 for the quarter ended March 31, 2026, or $(0.87) per diluted share, reflecting its new role as a holding company with results driven by equity-method investee GPGI Holdings.

The carrying value of GPGI’s equity method investment in GPGI Holdings jumped to $3,133.2, mainly from the Husky Technologies acquisition and related incremental investment. Underlying operations at GPGI Holdings generated $407.8 in net sales and combined Adjusted EBITDA of $88.8, split between CompoSecure and Husky.

Cash and cash equivalents at GPGI fell to $6.5 from $114.6, as the company invested heavily into GPGI Holdings in connection with the Husky Transaction while issuing new Class A shares and maintaining a modest quarterly dividend of $0.0025 per share.

Rhea-AI Summary

CompoSecure (CMPO) filed its Q3 2025 10‑Q, reflecting a structural shift to equity method accounting after the February 28, 2025 spin‑off of Resolute Holdings. The company reported a Q3 net loss of $174.7 million, largely from non‑cash fair‑value changes, including $117.3 million from the warrant liability and $57.6 million from earnout revaluation. These were partly offset by $39.6 million of earnings from its equity method investment in Holdings.

Liquidity improved: cash was $127.4 million at September 30, 2025, up from $77.5 million at year‑end. Stockholders’ equity turned positive to $152.5 million from a deficit. Warrant exercises brought in $154.4 million of cash during the nine months; the company also repurchased 647,782 shares for $12.2 million. The warrant liability declined to $41.4 million (from $104.2 million). A deferred tax asset stood at $289.2 million, while tax receivable agreement liabilities totaled $269.2 million (current and long‑term).

Shares outstanding were 124,961,235 as of September 30, 2025, and approximately 125,195,366 as of October 30, 2025.

Rhea-AI Summary

Q2-25 10-Q highlights (post spin-off & equity-method shift)

On 28-Feb-25 CompoSecure (CMPO) spun off Resolute Holdings and ceded control of operating subsidiary CompoSecure Holdings, L.L.C. (“Holdings”). Holdings is now carried as an equity-method investment. As a result, CMPO no longer records revenue or cost of sales; instead it reports its share of Holdings’ profit.

Income statement: For the quarter ended 30-Jun-25 CMPO booked $38.9 m of equity-method earnings, offset by non-cash fair-value losses on warrants (-$53.4 m) and earn-out liabilities (-$10.7 m). SG&A was $2.7 m. Net loss attributable to CMPO was -$26.1 m (-$0.26 per share) versus $33.6 m profit a year earlier.

Balance sheet: Deconsolidation shrank assets to $317 m from $474 m at 31-Dec-24. Cash fell sharply to $4.8 m. A $44.7 m equity-method asset was recognized. Liabilities declined to $424 m but still exceed assets, leaving a stockholders’ deficit of $106 m. Warrant liability expanded to $137.4 m.

Cash flow & liquidity: Operating cash inflow was $3.0 m YTD; $60.7 m was used in investing, mainly removal of Holdings’ cash. Financing outflow was $15.0 m. Net cash burn of $72.7 m heightens liquidity risk; CMPO depends on distributions from Holdings.

  • 102.4 m Class A shares outstanding; dual-class structure eliminated.
  • Deferred tax asset stands at $266.7 m.

Key takeaway: Equity-method profits remain solid, but parent-level cash is thin and non-cash mark-to-market items drive volatile GAAP results.